SB 1043 Hawaii Senate · 2025 Regular Session

RELATING TO TAXATION.

SB 1043 reduces the sales tax rate on nonprescription drugs (over-the-counter medications) by half. This policy directly affects pharmacies selling these products and consumers who purchase them. The tax reduction will take effect on July 1, 3000. The bill passed committee recommendation with amendments on February 10, 2025.

Issues: ✓ Budget & Taxes

Bill status passed 3 of 5 stages cleared

Introduction

Jan 2025

Committee Review

Mar 2025

Senate Passage

Mar 2025

House Passage

Governor

Introduced Jan 17, 2025 Last action Mar 19, 2025

Maddy AI version diff · 3 comparisons

What changed between versions

SB1043_SD1 → SB1043_SD2 · 5 edits

MODERATE

This bill updates the legislative document formatting and metadata for SB 1043, moving from Senate Draft 1 to Senate Draft 2. The substantive policy content regarding tax exemptions for groceries and nonprescription drugs remains unchanged. The primary differences are administrative updates including metadata fields, document headers, and the draft number designation.

TECHNICAL

Updated document metadata including author names (Lance Ching, Ainoa Naniole), timestamps, and revision numbers from SD1 to SD2

Changed Senate Draft designation from S.D. 1 to S.D. 2 in the header information

Updated description text to reflect SD2 instead of SD1 in the legislative summary section

Added metadata fields including file size, page count, and template revision information

Removed metadata headers and file information that were present in the SD1 version

Floor votes

How they voted

This bill passed the Senate by voice vote (no roll call recorded).

Full legislative history

Actions timeline

Total actions

Key actions

Committee

Mar 19, 2025

Committee

Reported from ECD (Stand. Com. Rep. No. 1379) as amended in HD 1, recommending passage on Second Reading and referral to FIN.

lower

Mar 14, 2025

Lower · Passed

The committee on ECD recommend that the measure be PASSED, WITH AMENDMENTS. The votes were as follows: 6 Ayes: Representative(s) Ilagan, Hussey, Tam, Templo, Todd, Matsumoto; Ayes with reservations: none; 0 Noes: none; and 1 Excused: Representative(s) Holt.

lower

Mar 6, 2025

Committee

Referred to ECD, FIN, referral sheet 19

lower

Mar 4, 2025

Introduced

Received from Senate (Sen. Com. No. 246) in amended form (SD 2).

lower

Mar 4, 2025

Upper · Passed

Report adopted; Passed Third Reading, as amended (SD 2). Ayes, 25; Aye(s) with reservations: none . Noes, 0 (none). Excused, 0 (none). Transmitted to House.

upper

Feb 27, 2025

Upper · Passed

The committee(s) on WAM recommend(s) that the measure be PASSED, WITH AMENDMENTS. The votes in WAM were as follows: 13 Aye(s): Senator(s) Dela Cruz, Moriwaki, Aquino, DeCoite, Elefante, Hashimoto, Inouye, Kanuha, Kidani, Kim, Lee, C., Wakai, Fevella; Aye(s) with reservations: none ; 0 No(es): none; and 0 Excused: none.

upper

Feb 21, 2025

Upper · Passed

The committee(s) on WAM will hold a public decision making on 02-27-25 10:30AM; Conference Room 211 & Videoconference.

upper

Feb 14, 2025

Committee

Reported from HHS/LBT (Stand. Com. Rep. No. 525) with recommendation of passage on Second Reading, as amended (SD 1) and referral to WAM.

upper

Feb 10, 2025

Upper · Passed

The committee(s) on LBT recommend(s) that the measure be PASSED, WITH AMENDMENTS. The votes in LBT were as follows: 5 Aye(s): Senator(s) Aquino, Lee, C., Ihara, Moriwaki, Fevella; Aye(s) with reservations: none ; 0 No(es): none; and 0 Excused: none.

upper

Feb 10, 2025

Upper · Passed

The committee(s) on HHS recommend(s) that the measure be PASSED, WITH AMENDMENTS. The votes in HHS were as follows: 4 Aye(s): Senator(s) San Buenaventura, Aquino, Hashimoto, Fevella; Aye(s) with reservations: none ; 0 No(es): none; and 1 Excused: Senator(s) Keohokalole.

upper

Feb 5, 2025

Upper · Passed

The committee(s) on HHS/LBT has scheduled a public hearing on 02-10-25 1:10PM; Conference Room 225 & Videoconference.

upper

Jan 23, 2025

Committee

Referred to HHS/LBT, WAM.

upper

Jan 17, 2025

Introduced

Introduced.

upper

3 primary · 1 co-sponsor